×
Please click
here
if you are not redirected within a few seconds.
All
News
Videos
Images
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
XORTX Therapeutics Prices $12m Public Offering
Yahoo News Singapore
By Sam Boughedda. Investing.com — XORTX Therapeutics (NASDAQ: XRTX) announced the pricing of its public offering on Wednesday,...
1 day ago
XORTX Reprices Warrants Issued in Connection with Previous Private Placements
WATE 6 On Your Side
CALGARY, Alberta, April 30, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX...
5 days ago
Dr. Allen Davidoff, XORTX Therapeutics: Developing Novel Therapies for Progressive Kidney Disease
Docwire News
DocWire News recently spoke with Allen Davidoff, Ph.D., the CEO of XORTX Therapeutics (pronounced Zor-tex). ...
5 days ago
XORTX Therapeutics Revises Warrant Terms - TipRanks.com
Tipranks
Xortx Therapeutics (TSE:XRTX) has released an update. XORTX Therapeutics Inc. has announced the amendment of exercise prices for over a million outstanding...
5 days ago
XORTX adjusts warrant terms and exercise price By Investing.com
Investing.com
CALGARY, Alberta - XORTX Therapeutics Inc. (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a pharmaceutical company specializing in the...
5 days ago
XORTX Announces Publication of Key Research in ADPKD
WFLA
CALGARY, Alberta, April 22, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX...
2 weeks ago
XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial
Yahoo Finance
(NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), stands out for its significant achievements in 2023 and ambitious plans for 2024.
1 month ago
XORTX Therapeutics Adjusts Warrant Exercise Price - TipRanks.com
Tipranks
Xortx Therapeutics (TSE:XRTX) has released an update. XORTX Therapeutics Inc., a pharmaceutical company specializing in kidney disease...
5 days ago
XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial
Yahoo Finance
April 21, 2023 – FDA granted Orphan Drug Designation for XRx-008 program for ADKPD, following review of February 1st submission of a...
1 month ago
XORTX Announces New Clinical Advisory Board Member
Yahoo Finance
CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX...
1 month ago